Asperfuranone from Aspergillus nidulans Inhibits Proliferation of Human Non-Small Cell Lung Cancer A549 Cells via Blocking Cell Cycle Progression and Inducing Apoptosis

CNU IR > Pharmacy and Science > Dept. of Pharmacy > Periodical Articles > Item 310902800/25384

Please use this identifier to cite or link to this item: https://ir.cnu.edu.tw/handle/310902800/25384

Title:	Asperfuranone from Aspergillus nidulans Inhibits Proliferation of Human Non-Small Cell Lung Cancer A549 Cells via Blocking Cell Cycle Progression and Inducing Apoptosis
Authors:	Clay C. C. Wang Yi-Ming Chiang Mike B. Praseuth Po-Lin Kuo Hsin-Lin Liang Ya-Ling Hsu
Contributors:	藥物科技研究所
Date:	2010-05
Issue Date:	2012-06-04 16:40:10 (UTC+8)
Publisher:	Wiley-Blackwell
Abstract:	Asperfuranone, a novel compound of genomic mining in Aspergillus nidulans, was investigated for its anti-proliferative activity in human non-small cell lung cancer A549 cells. To identity the anti-cancer mechanism of asperfuranone, we assayed its effect on apoptosis, cell cycle distribution, and levels of p53, p21 Waf1/Cip1, Fas/APO-1 receptor and Fas ligand. Enzyme-linked immunosorbent assay showed that the G0/G1 phase arrest might be due to p53-dependent induction of p21 Waf1/Cip1. An enhancement in Fas/APO-1 and its two form ligands, membrane-bound Fas ligand (mFasL) and soluble Fas ligand (sFasL), might be responsible for the apoptotic effect induced by asperfuranone. Our study reports here for the first time that the induction of p53 and the activity of Fas/Fas ligand apoptotic system may participate in the anti-proliferative activity of asperfuranone in A549 cells.
Relation:	Basic & Clinical Pharmacology & Toxicology 107(1)：p.583-589
Appears in Collections:	[Dept. of Pharmacy] Periodical Articles

Files in This Item:

File	Description	Size	Format
99_156_j.pdf		391Kb	Adobe PDF	383	View/Open
index.html		0Kb	HTML	2212	View/Open